- Home
- EXEL vs GTLS Comparison
EXEL vs GTLS Comparison
Compare EXEL & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- GTLS
- Stock Information
- Founded
- EXEL 1994
- GTLS 1859
- Country
- EXEL United States
- GTLS United States
- Employees
- EXEL N/A
- GTLS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- GTLS Metal Fabrications
- Sector
- EXEL Health Care
- GTLS Industrials
- Exchange
- EXEL Nasdaq
- GTLS Nasdaq
- Market Cap
- EXEL 10.4B
- GTLS 9.0B
- IPO Year
- EXEL 2000
- GTLS 1992
- Fundamental
- Price
- EXEL $38.12
- GTLS $199.38
- Analyst Decision
- EXEL Buy
- GTLS Buy
- Analyst Count
- EXEL 23
- GTLS 14
- Target Price
- EXEL $44.10
- GTLS $204.25
- AVG Volume (30 Days)
- EXEL 3.0M
- GTLS 761.1K
- Earning Date
- EXEL 11-04-2025
- GTLS 10-29-2025
- Dividend Yield
- EXEL N/A
- GTLS N/A
- EPS Growth
- EXEL 81.76
- GTLS N/A
- EPS
- EXEL 2.08
- GTLS 0.86
- Revenue
- EXEL $2,230,005,000.00
- GTLS $4,291,200,000.00
- Revenue This Year
- EXEL $9.14
- GTLS $12.01
- Revenue Next Year
- EXEL $12.51
- GTLS $10.00
- P/E Ratio
- EXEL $18.32
- GTLS $231.24
- Revenue Growth
- EXEL 10.73
- GTLS 5.47
- 52 Week Low
- EXEL $31.90
- GTLS $104.60
- 52 Week High
- EXEL $49.62
- GTLS $220.03
- Technical
- Relative Strength Index (RSI)
- EXEL 46.88
- GTLS 49.84
- Support Level
- EXEL $33.76
- GTLS $199.35
- Resistance Level
- EXEL $40.63
- GTLS $199.99
- Average True Range (ATR)
- EXEL 1.31
- GTLS 0.46
- MACD
- EXEL 0.07
- GTLS -0.20
- Stochastic Oscillator
- EXEL 63.54
- GTLS 3.05
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.